These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7336471)

  • 1. High pressure liquid chromatography on labetalol in serum or plasma.
    Woodman TF; Johnson B
    Ther Drug Monit; 1981; 3(4):371-5. PubMed ID: 7336471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detection.
    Meredith PA; McSharry D; Elliott HL; Reid JL
    J Pharmacol Methods; 1981 Dec; 6(4):309-14. PubMed ID: 7334812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic assay for labetalol in human plasma using a PRP-1 column and fluorometric detection.
    Alton KB; Leitz F; Bariletto S; Jaworsky L; Desrivieres D; Patrick J
    J Chromatogr; 1984 Nov; 311(2):319-28. PubMed ID: 6520179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive high-performance liquid chromatographic method for the determination of labetalol in human plasma using fluorimetric detection.
    Oosterhuis B; van den Berg M; van Boxtel CJ
    J Chromatogr; 1981 Nov; 226(1):259-65. PubMed ID: 7320152
    [No Abstract]   [Full Text] [Related]  

  • 5. High-performance liquid chromatographic method for the determination of labetalol in plasma using ultraviolet detection.
    Hidalgo IJ; Muir KT
    J Chromatogr; 1984 Jan; 305(1):222-7. PubMed ID: 6707148
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved liquid-chromatographic assay of labetalol in plasma.
    Luke DR; Matzke GR; Clarkson JT; Awni WM
    Clin Chem; 1987 Aug; 33(8):1450-2. PubMed ID: 3608164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of fluorescence detection for the determination of labetalol in plasma by high-performance liquid chromatography.
    Ostrovská V; Svobodová X; Pechová A; Kusala S; Svoboda M
    J Chromatogr; 1988 Jul; 446():323-7. PubMed ID: 3209660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of labetalol in human plasma by high-performance liquid chromatography.
    Dusci LJ; Hackett LP
    J Chromatogr; 1979 Jul; 175(1):208-10. PubMed ID: 546907
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined use of an automated sample processor and a polymer-based high-performance liquid chromatographic column to determine the pharmacokinetics of labetalol in man.
    Bates J; Carey PF; Godward RE
    J Chromatogr; 1987 Jun; 395():455-61. PubMed ID: 3624360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.
    McNeil JJ; Anderson AE; Louis WJ; Morgan DJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):157S-161S. PubMed ID: 526397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labetalol steady-state pharmacokinetics in hypertensive patients.
    McNeil JJ; Anderson AE; Louis WJ; Raymond K
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):75S-80S. PubMed ID: 7093102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paired-ion chromatography and high performance liquid chromatography of labetalol in feeds.
    Townley ER; Ross B
    J Assoc Off Anal Chem; 1980 Nov; 63(6):1262-5. PubMed ID: 7451388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of single and multiple dose pharmacokinetic/pharmacodynamic modeling of the antihypertensive effects of labetalol.
    Maronde RF; Robinson D; Vlachakis ND; Barr JW; Chung M; Zampaglione N; Medakovic M
    Am J Med; 1983 Oct; 75(4A):40-6. PubMed ID: 6356898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of amosulalol in human plasma using solid-phase extraction combined with liquid chromatography and ultraviolet detection.
    Gwak HS; Noh ES; Lee NY; Chun IK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):109-13. PubMed ID: 15734149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapy.
    Sanders GL; Routledge PA; Ward A; Davies DM; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):153S-155S. PubMed ID: 526396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic assay for dilevalol in human plasma and urine using a PRP-1 column and fluorimetric detection.
    Alton KB; Petruzzi RF; Patrick JE
    J Chromatogr; 1988 Mar; 425(2):363-72. PubMed ID: 2897376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive chiral high-performance liquid chromatographic assay for labetalol in biological fluids.
    Dakers JM; Boulton DW; Fawcett JP
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):215-20. PubMed ID: 9518153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased first-pass metabolism of labetalol in chronic liver disease.
    Homeida M; Jackson L; Roberts CJ
    Br Med J; 1978 Oct; 2(6144):1048-50. PubMed ID: 709214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive high-performance liquid chromatographic method for the determination of labetalol diastereoisomers in plasma samples without derivatization.
    Grellet J; Michel-Gueroult P; Ducint D; Saux MC
    J Chromatogr; 1994 Jan; 652(1):59-66. PubMed ID: 8014228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive microbore high-performance liquid chromatographic assay for labetalol in the biological fluids of pregnant sheep.
    Yeleswaram K; Axelson JE; Rurak DW
    J Chromatogr; 1991 Apr; 565(1-2):383-90. PubMed ID: 1874882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.